Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

A nurse-led hair service reduced waiting times and improved patient satisfaction and outcomes for alopecia areata treatment.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Alefacept does not effectively treat severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.